Pfizer saw the highest growth of 1.14% in patent filings in May and 1.08% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.02% and grants by 1.08%. GlobalData’s DataBook provides a comprehensive analysis of Pfizer‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Pfizer has been focused on protecting inventions in United States(US) with 93 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 31% filings and 18% grants. The United States(US), World Intellectual Property Organization(WIPO), Australia(AU), and European Patent Office(EPO) patent Office are among the top ten patent offices where Pfizer is filings its patents. Among the top granted patent authorities, Pfizer has 18% of its grants in United States(US), 18% in Israel(IL) and 9% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Pfizer
Pfizer stands in second position with respect to its patent publications among its competitors.
Patents related to rare diseases and nanomedicine lead Pfizer's portfolio
Pfizer has the highest number of patents in rare diseases followed by, nanomedicine and climate change. For rare diseases, nearly 48% of patents were filed and 49% of patents were granted in Q2 2024.
Breast cancer related patents lead Pfizer portfolio followed by prostate cancer, and leukemia
Pfizer has highest number of patents in breast cancer followed by prostate cancer, leukemia, ovarian cancer, and lung cancer. For breast cancer, nearly 2% of patents were filed and 2% of patents were granted in Q2 2024.
For comprehensive analysis of Pfizer's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
